B

Bonus Biogroup Ltd
TASE:BONS

Watchlist Manager
Bonus Biogroup Ltd
TASE:BONS
Watchlist
Price: 15 ILS 0.67%
Market Cap: 183.5m ILS
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+22%
Revenue
Forecast
+15%
Operating Income
Forecast
N/A
Net Income
Forecast
-4%

Wall Street
Price Targets

BONS Price Targets Summary
Bonus Biogroup Ltd

There are no price targets for BONS.
BONS Lowest Forecast
Wall Street Target
Not Available
BONS Average Forecast
Wall Street Target
Not Available
BONS Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Bonus Biogroup Ltd Competitors:
Price Targets
ACAD
ACADIA Pharmaceuticals Inc
76% Upside
RYTM
Rhythm Pharmaceuticals Inc
35% Upside
SRZN
Surrozen Inc
245% Upside
002007
Hualan Biological Engineering Inc
22% Upside
ACAD
ACADIA Pharmaceuticals Inc
76% Upside
RYTM
Rhythm Pharmaceuticals Inc
35% Upside
SRZN
Surrozen Inc
245% Upside
002007
Hualan Biological Engineering Inc
22% Upside
300685
Amoy Diagnostics Co Ltd
48% Upside
S
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
2% Downside
K
2162
KeyMed Biosciences Inc
48% Upside
ANAB
AnaptysBio Inc
133% Upside

Revenue
Forecast

Revenue Estimate
Bonus Biogroup Ltd

Revenue forecast
is not available for
Bonus Biogroup Ltd

Operating Income
Forecast

Operating Income Estimate
Bonus Biogroup Ltd

Operating Income forecast
is not available for
Bonus Biogroup Ltd

Net Income
Forecast

Net Income Estimate
Bonus Biogroup Ltd

Net Income forecast
is not available for
Bonus Biogroup Ltd

See Also

Summary
BONS intrinsic value, competitors valuation, and company profile.
DCF Valuation
BONS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BONS stock valuation using valuation multiples.
Wall Street Estimates
BONS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BONS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BONS's stock price target?
Not Available

BONS doesn't have any price targets made by Wall Street professionals.

Back to Top
ALPHA SPREAD
Follow us
Join more than 245,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.